BLOGS & NEWS

Nilotinib as an alternate medication for Imatinib Resistant CML

Nilotinib as an alternate medication for Imatinib Resistant CML

Chronic Myeloid Leukemia and its treatment with Nilotinib / Tasigna Chronic Myeloid Leukemia or CML forms from the clonal expansion of stem cells (pluripotent hematopoietic) that contains an active fusion gene / protein known as BCR/ABL. This protein shows organized tyrosine activity and enables the leukemic cells to ...

Read More
Votrient Treatment for Renal Cell Cancer and Soft Tissue Sarcoma

Votrient Treatment for Renal Cell Cancer and Soft Tissue Sarcoma

Votrient manufactured by GlaxoSmithKline was approved by FDA for renal cell cancer (RCC) treatment. And in 2012, Votrient obtained an additional approval from FDA for second indication, i.e. it can now be administered to patients who have received chemotherapy and have a certain subtypes of Soft Tissue Sarcoma (STS). ...

Read More
Pazopanib Votrient Targeted Therapy for Treating Soft Tissue Sarcoma

Pazopanib Votrient Targeted Therapy for Treating Soft Tissue Sarcoma

Soft-tissue sarcoma is a rare kind of cancer which forms in the tissues that surround body structures. Such tissues include the blood vessels, nerves, tendons, muscle, fat and lining of the joints. ...

Read More
Role of Lupron Depot in treating Endometriosis

Role of Lupron Depot in treating Endometriosis

Lupron Depot (Leuprorelin / leuprolide acetate for depot suspension) is a medication prescribed for treating acute endometriosis in women. It can also be used to lessen certain symptoms such as painful menstrual periods, pelvic pain and abdominal bloating. It is a hormonal agent (GnRH antagonist). ...

Read More
Is Lupron Depot effective in the treatment of Prostate Cancer

Is Lupron Depot effective in the treatment of Prostate Cancer

What to expect from Lupron treatment The Brand name of Leuprorelin / Leuprolide acetate. This hormone therapy is generally used by doctors in combination with other drugs to treat Prostate Cancer. ...

Read More
How Imatinib Gleevec Transformed Leukemia Treatment and Cancer Research

How Imatinib Gleevec Transformed Leukemia Treatment and Cancer Research

Gleevec (Imatinib) was developed with primarily with the help of researches conducted by National Cancer Institute (NCI), and Imatinib was one of the discoveries they made. This Drug has drastically improved the outcomes of patients who were suffering from Blood Cancer primarily Chronic Myelogenous Leukaemia. And due t ...

Read More
How is Goserelin used for the treatment of Breast Cancer

How is Goserelin used for the treatment of Breast Cancer

Goserelin (Brand Zoladex) is a medication used for treating Breast Cancer. It is a hormonal therapy drug that is given as an injection by a doctor or a nurse in a hospital setting or a clinic. ...

Read More
Selling rights of Zoladex medication sold to TerSera for USA and Canada

Selling rights of Zoladex medication sold to TerSera for USA and Canada

AstraZeneca has sold their right to sell Zoladex (generic of Goserelin) in the United States and Canada to TerSera Therapeutics LLC, headquartered at Illinois, USA. And the main reason for this big move is because AstraZeneca is keen to focus more on newer Oncology products. ...

Read More
The Effects of Gefitinib in EGFR Mutation Breast Cancer

The Effects of Gefitinib in EGFR Mutation Breast Cancer

Nearly 1 in 5 cases of breast cancer, high levels of a protein known as epidermal growth factor receptor or EGFR has been observed. This protein can cause the cancer cells to grow at a faster rate. This results in shorter survival period for patients of breast cancer and also build up resistance to hormonal therapy. ...

Read More
TOP